Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
暂无分享，去创建一个
R. Laborde | A. Tefferi | M. Patnaik | E. Padron | T. Lasho | R. Ketterling | A. Pardanani | R. Komrokji | C. Hanson | A. Al-Kali | C. Finke | R. Knudson | N. Ali | J. Hodnefield | Rebecca R. Laborde